卡硝唑结构式
|
常用名 | 卡硝唑 | 英文名 | Carnidazole |
---|---|---|---|---|
CAS号 | 42116-76-7 | 分子量 | 244.271 | |
密度 | 1.4±0.1 g/cm3 | 沸点 | 422.8±51.0 °C at 760 mmHg | |
分子式 | C8H12N4O3S | 熔点 | N/A | |
MSDS | 中文版 美版 | 闪点 | 209.5±30.4 °C | |
符号 |
GHS05, GHS07 |
信号词 | Danger |
卡硝唑用途Carnidazole 是一种硝基咪唑类的抗原虫剂 (antiprotozoal)。可用于滴虫感染的研究。 |
中文名 | 卡硝唑 |
---|---|
英文名 | O-methyl N-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]carbamothioate |
英文别名 | 更多 |
描述 | Carnidazole 是一种硝基咪唑类的抗原虫剂 (antiprotozoal)。可用于滴虫感染的研究。 |
---|---|
相关类别 | |
靶点 |
Antiprotozoal[1] |
参考文献 |
密度 | 1.4±0.1 g/cm3 |
---|---|
沸点 | 422.8±51.0 °C at 760 mmHg |
分子式 | C8H12N4O3S |
分子量 | 244.271 |
闪点 | 209.5±30.4 °C |
精确质量 | 244.063004 |
PSA | 116.99000 |
LogP | 0.72 |
外观性状 | 固体 |
蒸汽压 | 0.0±1.0 mmHg at 25°C |
折射率 | 1.627 |
储存条件 | -20°C |
计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:1 3.氢键受体数量:5 4.可旋转化学键数量:4 5.互变异构体数量:2 6.拓扑分子极性表面积:117 7.重原子数量:16 8.表面电荷:0 9.复杂度:271 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
符号 |
GHS05, GHS07 |
---|---|
信号词 | Danger |
危害声明 | H317-H318 |
警示性声明 | P280-P305 + P351 + P338 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | C |
危险品运输编码 | NONH for all modes of transport |
RTECS号 | FD3912000 |
海关编码 | 2933290090 |
海关编码 | 2933290090 |
---|---|
中文概述 | 2933290090. 其他结构含非稠合咪唑环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Determination of the antitubercular drug PA-824 in rat plasma, lung and brain tissues by liquid chromatography tandem mass spectrometry: application to a pharmacokinetic study.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 988 , 187-94, (2015) A selective, sensitive and high performance liquid chromatography-tandem mass spectrometry (LC-(ESI)MS/MS) method has been developed and validated for the quantification of the potent antitubercular d... |
|
In vitro nitroimidazole resistance of Trichomonas gallinae and successful therapy with an increased dosage of ronidazole in racing pigeons (Columba livia domestica).
J. Vet. Pharmacol. Ther. 15(4) , 409-15, (1992) Six out of eight different Trichomonas gallinae strains isolated from racing pigeons proved to be resistant to the nitroimidazole drugs ronidazole, carnidazole and metronidazole. The minimal cytocidal... |
|
Structural characterization of drugs and oxygenated metabolites by laser microprobe mass spectrometry (LAMMA).
Biomed. Environ. Mass Spectrom. 16(1-12) , 121-9, (1988) Laser microprobe mass analysis (LAMMA) was used for the structural characterization of polyfunctional drugs and their oxygenated metabolites, in particular the N-oxides. The spectra usually yield the ... |
ME 108 |
Spartrix |
Carnidazole |
[2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl]carbamothioic Acid O-Methyl Ester |
Carbamothioic acid, N-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-, O-methyl ester |
O-Methyl [2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]carbamothioate |
EINECS 255-663-0 |
UNII-RH5KI819JG |